The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 21, 2018

Filed:

Apr. 04, 2014
Applicant:

The Board of Trustees of the Leland Stanford Junior University, Stanford, CA (US);

Inventors:

Ryan D. Schubert, San Francisco, CA (US);

Robert C. Axtell, Oklahoma City, OK (US);

Jeffrey Edward Dunn, San Jose, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 15/14 (2006.01); A61K 31/785 (2006.01); G01N 33/569 (2006.01); G01N 33/50 (2006.01); A61K 38/21 (2006.01); G01N 15/10 (2006.01);
U.S. Cl.
CPC ...
G01N 33/56972 (2013.01); A61K 31/785 (2013.01); A61K 38/215 (2013.01); G01N 15/14 (2013.01); G01N 33/5052 (2013.01); G01N 2015/1006 (2013.01); G01N 2015/1486 (2013.01); G01N 2333/525 (2013.01); G01N 2333/565 (2013.01); G01N 2469/10 (2013.01); G01N 2800/285 (2013.01); G01N 2800/52 (2013.01);
Abstract

Compositions and methods are provided for classification of individuals suffering from a demyelinating disease into groups that are informative of the individual's responsiveness or lack of responsiveness to treatment with a J3-interferon (IFNJ3) acting therapy. In particular, it is shown that the effective immunomodulatory treatment of demyelinating disease with IFNJ3 is associated with an increase in circulating transitional B cells in the patient. Diseases of interest include without limitation inflammatory demyelinating diseases of the central nervous system, e.g. multiple sclerosis, neuromyelitis optica (NMO), experimental autoimmune encephalitis (EAE), acute disseminated encephalomyelitis (ADEM), etc.


Find Patent Forward Citations

Loading…